USE OF THE HOLMIUM-YAG (HO YAG) LASER FOR TREATMENT OF SUPERFICIAL BLADDER-CARCINOMA
USE OF THE HOLMIUM-YAG (HO YAG) LASER FOR TREATMENT OF SUPERFICIAL BLADDER-CARCINOMA
复制标题
DOI：
10.1002/lsm.1900140303
复制
发表时间：
1994-01-01
影响因子：
2.4
通讯作者：
JOHNSON, DE
中科院分区：
文献类型：
--
作者：
JOHNSON, DE
这是北美第一份描述使用钬:YAG (Ho:YAG) 激光治疗浅表性膀胱癌患者的报告。 15 名患者，总共 52 个复发性浅表膀胱肿瘤，接受了内窥镜激光消融术治疗其病灶。未发生术中或迟发并发症。在激光照射后 3 个月进行的随访膀胱镜检查中，四名患者 (27%) 没有疾病； 8 名患者 (53%) 出现场外复发；三名患者 (20%) 被归类为现场复发。我们的结论是，使用 Ho:YAG 进行内窥镜治疗浅表性膀胱肿瘤患者是可行的，并且在临床上有用，并且在激光照射过程中不会感觉到疼痛或不适，也不需要留置导尿管，这使得它比传统电切除技术更有利于选定的患者。 (C) 1994 年 Wiley-Liss 公司
This is the first North American report describing the use of the holmium:YAG (Ho:YAG) laser to treat patients with superficial bladder carcinoma. Fifteen patients, with a total of 52 recurrent superficial bladder tumors, underwent endoscopic laser photoablation of their lesions. No intraoperative or delayed complications occurred. At follow-up cystoscopy performed 3 months after lasing, four patients (27%) were without disease; eight patients (53%) had out-of-field recurrences; and three patients (20%) were classified as having in-field recurrences. We conclude that using the Ho:YAG for endoscopic treatment of patients with superficial bladder tumors is both feasible and clinically useful and that the lack of perceived pain or discomfort during lasing, as well as the lack of need for an in-dwelling urethral catheter, makes it advantageous for selected patients over conventional electroresection techniques. (C) 1994 Wiley-Liss, Inc.